Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence in Oncology: Clinical Applications, Challenges, and Opportunities.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

In Reply to Hannoun-Levi et al.

International journal of radiation oncology, biology, physics·2026
Same author

Pupillary Response Patterns in Patients with Known Substance Use Based on Stimulus Chromaticity; A Pedagogically Based Assessment.

Current eye research·2025
Same author

The Role of Immunotherapy and Radiation Therapy in the Treatment of Breast Cancer.

Biomedicines·2025
Same author

Randomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer.

Breast cancer research and treatment·2025
Same author

Gastric dilation following vertical sleeve gastrectomy reflects adaptive stem cell-driven regeneration without association with weight regain or increased cancer risk.

Life sciences·2025

Related Experiment Video

Updated: Jul 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Inferior vena cava filters for recurrent thrombosis: current evidence.

Salil H Patel1, Rima Patel

  • 1Department of Medicine, The Methodist Hospital and Christus St. Joseph Hospital, Houston, Texas 77002, USA. patelsa@mir.wustl.edu

Texas Heart Institute Journal
|July 12, 2007
PubMed
Summary

Inferior vena cava filters help prevent pulmonary embolism but carry thrombotic risks. This review examines filter-related complications and concurrent anticoagulant therapy use.

More Related Videos

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

Related Experiment Videos

Last Updated: Jul 13, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis
05:37

Stenosis of the Inferior Vena Cava: A Murine Model of Deep Vein Thrombosis

Published on: December 22, 2017

Area of Science:

  • Medical Devices
  • Cardiovascular Medicine
  • Thrombosis Research

Background:

  • Inferior vena cava (IVC) filters are utilized to prevent pulmonary embolism (PE).
  • Clinical evidence supporting IVC filter use often comes from limited retrospective studies.
  • Understanding device-associated risks is crucial for patient safety.

Purpose of the Study:

  • To review the incidence of thrombotic complications linked to IVC filters.
  • To discuss the role and efficacy of anticoagulant therapy alongside IVC filter placement.
  • To provide a comprehensive overview of IVC filter use and associated morbidities.

Main Methods:

  • Literature review of studies on IVC filters and thrombotic events.
  • Analysis of data on vena cava thrombosis, insertion-site thrombosis, and recurrent PE.
  • Evaluation of concurrent anticoagulant therapy in patients with IVC filters.

Main Results:

  • Thrombotic complications are a significant concern with IVC filters.
  • The efficacy of IVC filters must be weighed against their associated risks.
  • Concurrent anticoagulant therapy may influence complication rates.

Conclusions:

  • IVC filter use requires careful consideration of thrombotic risks.
  • Further research is needed to optimize the use of IVC filters and anticoagulation.
  • Assessing device-associated morbidity is essential for informed clinical decisions.